GRID-REF 37°47′N 122°25′W
DISPATCH 03/26 · 25 Jul 2026
BATTLEPOLICY
Startup to front line. Strategy to consequence.
Lexicon · Russia

Lancet

Russia's dominant loitering munition — an electric X-wing anti-materiel drone with shaped-charge, fragmentation, and thermobaric warheads, used at mass scale against artillery, armor, and air-defense assets in Ukraine.

Lancet
FIG.01 · Russia Image - Lancet. Photo by Mztourist, CC BY 4.0, via Wikimedia Commons.
Russia’s dominant loitering munition — a cheap, electric X-wing one-way attack drone that turned the artillery duel in Ukraine into a cost-exchange crisis, striking howitzers, armor, and air-defense systems with shaped-charge, fragmentation, and thermobaric warheads.

Overview

The Lancet, produced by ZALA Aero (part of the Kalashnikov Concern), is a family of tube- or rail-launched loitering munitions that have become the most prolific and tactically significant one-way attack systems in Russian service. Two main airframes — the smaller Izdeliye-52 and the larger Izdeliye-51 — share a distinctive dual-cruciform (X-wing) layout and a quiet electric-pusher propulsion. Designed to loiter over a target area while a separate Z-16 reconnaissance UAV provides the operator with live video, the Lancet dives onto its target at speeds up to 300 km/h. Its combination of low cost (~$30,000–35,000 per round), four distinct warhead options, and immunity to most hard-kill active protection systems has made it a persistent threat to Western-supplied artillery, armour, and air-defence assets in Ukraine.

Development

ZALA Aero first displayed the Lancet at the ARMY-2019 military expo outside Moscow, and according to Wikipedia the type was combat-tested in Syria in 2020 before mass fielding during the Russian invasion of Ukraine in 2022. The design drew on the earlier, smaller KUB-BLA loitering munition but introduced a larger airframe, heavier warheads, and the twin-boom X-wing configuration that gives the Lancet its distinctive silhouette. By early 2023 the weapon was being used at scale, and production ramped through 2024–2025 to meet the voracious demand of front-line units, with the manufacturer claiming the ability to produce thousands of rounds per month.

🔒 The rest of the Lancet file is for BattlePolicy Pro members. Stop here and you miss the part that actually matters: how it performs and where it falls short, its combat record, how it stacks up head-to-head against its real counterparts, the complete specifications table, and our analysts’ procurement, supplier and assessment notes. Unlock the full file with BattlePolicy Pro →
FIELD DISPATCH · WEEKLY

BattlePolicy Weekly — free.

Defense tech, startups, and security — weekly.

Related